(From Betterhumans). There are many necessary steps in bringing a new therapy to the market. One of the most basic ones is demonstrating that you can do many times over what you have already accomplished a few times in early trials. It looks like stem cell therapies are over this cost-effective mass production hurdle, which is very encouraging. As you should all know by now, stem cells and theraputic cloning look to be the strongest basis for powerful near-term regenerative therapies: the medicine that will extend our healthy lives.